VDP Stock Overview
Produces and sells pharmaceutical products under the Vidipha brand. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 1/6 |
Vidipha Central Pharmaceutical Joint Stock Company Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₫35,000.00 |
| 52 Week High | ₫40,800.00 |
| 52 Week Low | ₫30,083.33 |
| Beta | 0 |
| 11 Month Change | 6.06% |
| 3 Month Change | 1.45% |
| 1 Year Change | 10.24% |
| 33 Year Change | 12.60% |
| 5 Year Change | 34.83% |
| Change since IPO | 23.71% |
Recent News & Updates
Recent updates
Shareholder Returns
| VDP | VN Pharmaceuticals | VN Market | |
|---|---|---|---|
| 7D | 2.9% | 0.1% | -2.3% |
| 1Y | 10.2% | 19.4% | 7.2% |
Return vs Industry: VDP underperformed the VN Pharmaceuticals industry which returned 19.4% over the past year.
Return vs Market: VDP exceeded the VN Market which returned 7.2% over the past year.
Price Volatility
| VDP volatility | |
|---|---|
| VDP Average Weekly Movement | 3.5% |
| Pharmaceuticals Industry Average Movement | 3.4% |
| Market Average Movement | 3.4% |
| 10% most volatile stocks in VN Market | 6.5% |
| 10% least volatile stocks in VN Market | 1.8% |
Stable Share Price: VDP has not had significant price volatility in the past 3 months compared to the VN market.
Volatility Over Time: VDP's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | n/a | Hoa Van Hoang | www.vidipha.com.vn |
Vidipha Central Pharmaceutical Joint Stock Company produces and sells pharmaceutical products under the Vidipha brand. The company primarily provides antibiotics, anti-inflammatory, vitamins and mineral salts, pain relievers, antipyretics, anti-allergy drugs, and other medicines for the treatment of worm, fluke, respiratory, gastrointestinal, and skin diseases. It offers its products in the form of compress and capsule Pills, Powdered granules, powder and liquid Injections, Syrups, drinking tubes, Eye and nose drops, Topical creams, and ointments.
Vidipha Central Pharmaceutical Joint Stock Company Fundamentals Summary
| VDP fundamental statistics | |
|---|---|
| Market cap | ₫772.93b |
| Earnings (TTM) | ₫0 |
| Revenue (TTM) | n/a |
n/a
P/E Ration/a
P/S RatioIs VDP overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| VDP income statement (TTM) | |
|---|---|
| Revenue | ₫0 |
| Cost of Revenue | ₫0 |
| Gross Profit | ₫0 |
| Other Expenses | ₫0 |
| Earnings | ₫0 |
Last Reported Earnings
n/a
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did VDP perform over the long term?
See historical performance and comparison